A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002)

NCT01656408 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Isolated Systolic Hypertension

Interventions

DRUG: MK-8150
DRUG: Placebo for MK-8150

Sponsor

Merck Sharp & Dohme LLC